# Market Research - Acceptability Study for a Range of MCT Products

> **NCT04309149** · NA · COMPLETED · sponsor: **Dr. Schär AG / SPA** · enrollment: 12 (actual)

## Conditions studied

- Ketosis
- Epilepsy
- Ketogenic Diet
- Fatty Acid Oxidation Disorder
- Malabsorption

## Interventions

- **DIETARY_SUPPLEMENT:** MCT fats

## Key facts

- **NCT ID:** NCT04309149
- **Lead sponsor:** Dr. Schär AG / SPA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04309149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04309149, "Market Research - Acceptability Study for a Range of MCT Products". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04309149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*